[107] In October 1998, Lilly formed a 50-50 joint venture with Icos, a Bothell, Washington-based biotechnology company, to develop and commercialize Tadalafil (Cialis), for the treatment of erectile dysfunction
Rapid Weight Change An increase in weight around the stomach, thigh, and hip areas can lead to the creation of stretch marks
Future therapeutic approaches may involve: Microbiome-targeted therapies Gut-derived peptide treatments Personalized nutrition based on microbial composition These emerging strategies reflect a broader shift in metabolic medicine toward addressing root causes rather than simply managing symptoms
Savannah Men Report the Following Benefits of PT-141 Peptide Therapy PT-141 and Erectile Dysfunction PT-141 is a peptide developed based on the Melanotan 2, which is known to be a synthetically produced variant of a peptide hormone
Int J Cancer 2002;101:710